Jingxin Pharmaceutical (002020): slightly higher performance, expected new products to continue heavy

Jingxin Pharmaceutical (002020): slightly higher performance, expected new products to continue heavy Event: The company announced the 2019 semi-annual results report: H1 in 2019 achieved operating income18. USD 5.9 billion, an annual increase of 31. 92%; net profit attributable to mother is 3. 2.6 billion, an annual increase of 52. 89%, EPS per share is […]

Read MoreRead More